🔎 Trials Near Me

Akèy › Leksemi mieloïd egi › Arizona › Phoenix

Etid klinik pou Leksemi mieloïd egi nan Phoenix, AZ

13 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote Phoenix (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Cancer Center at Saint Joseph's, Phoenix
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • Mayo Clinic Hospital in Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05564390

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • Mayo Clinic Hospital in Arizona, Phoenix
Laj 18 a 59 · Tout sèks · Mizajou Sep 22, 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Ap rekriteFaz 3
  • Phoenix Childrens Hospital, Phoenix
6 Months – 21 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT04293562

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Ap rekriteFaz 2
  • Mayo Clinic Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Ap rekriteFaz 1/2
  • Mayo Clinic, Phoenix
Laj 12 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT04588922

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Ap rekriteFaz 3
  • Phoenix Children's Hospital, Phoenix
29 Days – 21 Years · Tout sèks · Mizajou Aug 24, 2026 · NCT05183035

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • Phoenix Children's Hospital, Phoenix
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Caris Chromoseq Data Collection

Ap rekriteEtid obsèvasyon
  • Caris Life Sciences, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07680868

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

Ap rekriteFaz 1
  • Phoenix Children's Hospital, Phoenix
Jiska laj 21 · Tout sèks · Mizajou Apr 22, 2026 · NCT05101551

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Ap rekriteFaz 1/2
  • Mayo Clinic Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT05732103

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Ap rekriteFaz 1
  • Mayo Clinic - Phoenix, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT05735184

Etid Leksemi mieloïd egi nan lòt vil

Lòt etid nan Phoenix

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.